Pulse: EKG

Ventricular Fibrillation or Not?
Parmatma Greeley MD, PGY-3

Mr. B is an 84 year-old African-American male veteran
with a history of type 2 diabetes and hypertension who was
admitted to the VA hospital for hypertensive urgency. In
the ICU, he became unresponsive and pulseless. Telemetry
showed “ventricular fibrillation” which spontaneously
converted to sinus rhythm. An echocardiogram showed an
ejection fraction of 60%. An ECG performed prior to the
ventricular arrhythmia is shown below.
The major findings of this ECG are bradycardia, QT
prolongation, U waves, and T wave alternans (TWA) best
seen in leads V3, V4, and V5. With these findings, it is
important to ask if the patient was really in ventricular
fibrillation.
Ventricular fibrillation rarely spontaneously remits. The
findings of QT prolongation and TWA prior to the event
are suggestive of a ventricular tachyarrhythmia. This
patient had normal electrolytes and was on no drugs that
typically cause QT prolongation. He was sent to a
hospital with an electrophysiology department and given
the diagnosis of long QT syndrome and TWA. Mr. B’s
risk of developing another tachyarrhythmia was
considered very high therefore an Automatic Implantable
Cardioverter Defibrillator (AICD) was placed.
TWA is a variation in the shape of the T waveform seen
every other beat representing a change in the intrinsic
repolarization of the heart. It is a highly sensitive and
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specific marker of susceptibility to ventricular
arrhythmias and sudden cardiac death. TWA often
precedes conditions like Prinzmetal’s angina, acute
myocardial infarction, electrolyte imbalances and long
QT syndrome. TWA is detected by measurement of
microvolt level. TWA on surface Laplacian ECG is
commonly associated with long QT syndrome. TWA
seen by the naked eye on ECG is a rare finding. Testing
for TWA may identify patients at increased risk who
fulfill MADIT II criteria for AICD placement.
Thank you to Dr. Reddy for this interesting ECG.
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